Lumiera Health Inc. (the 'Company' or 'Lumiera') announced the launch of its Awaye™ pain relief cream in the US market. The first shipment of Awaye™ has been sent to Amazon.com's distribution center and will soon be available to American consumers. Awaye™ provides a new generation of relief from acute and chronic pain by exploiting the CB2 receptors of the endocannabinoid system, the body's built-in pain and inflammation defense system.

Awaye™ is a unique Health Canada approved topical cream that provides relief from pain through complimentary mechanisms of action not found in any other product currently available on the market.